Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008-2016

• Asıl Yazarlar: Penina Haber (Yazar), Muhammad Amin (Yazar), Carmen Ng (Yazar), Eric Weintraub (Yazar), Michael M. McNeil (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2018-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

A 2018 manufacturer post-licensure safety study identified a possible association between Rotarix (RV1) rotavirus vaccine and lower respiratory tract infections (LRTI) in infants within 0-6 days following receipt of RV1 dose 1. We reviewed reports to the Vaccine Adverse Event Reporting System (VAERS...